The loss of p53 leads to exaggerated mitochondrial fragmentation, which correlates with aggressive cancer phenotypes, epithelial-to-mesenchymal transition (EMT), and enhanced metastatic capacity [28]. This evidence concerns the gene TP53 and cancer.